Cargando…

Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment

In patients with atherosclerotic cardiovascular disease (ASCVD) under statin treatment, the influence of on-treatment level of high-density lipoprotein cholesterol (HDL-C) on cardiovascular (CV) events is controversial. Statin-treated patients were selected from the Taiwanese Secondary Prevention fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yi-Heng, Tseng, Wei-Kung, Yin, Wei-Hsian, Lin, Fang-Ju, Wu, Yen-Wen, Hsieh, I-Chang, Lin, Tsung-Hsien, Sheu, Wayne Huey-Herng, Yeh, Hung-I, Chen, Jaw-Wen, Wu, Chau-Chung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736267/ https://www.ncbi.nlm.nih.gov/pubmed/33318590 http://dx.doi.org/10.1038/s41598-020-78828-8

Ejemplares similares

Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? ‒ Data from a multicenter registry cohort study in Taiwan
por: Yeh, Yen-Ting, et al.
Publicado: (2017)

Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus
por: Lin, Fang-Ju, et al.
Publicado: (2017)

Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in Taiwan
por: Liu, Patrick Yan-Tyng, et al.
Publicado: (2023)

The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease
por: Hsuan, Chin-Feng, et al.
Publicado: (2022)

Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan
por: Leu, Hsin-Bang, et al.
Publicado: (2017)

The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
por: Wu, Jia-Ru, et al.
Publicado: (2019)

Optimal achieved blood pressure for patients with stable coronary artery disease
por: Huang, Chin-Chou, et al.
Publicado: (2017)

Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
por: Ho, Sing-Kong, et al.
Publicado: (2019)

The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
por: Ho, Sing-Kong, et al.
Publicado: (2018)

Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease
por: Wu, Yen-Wen, et al.
Publicado: (2020)

Prognostic indicators for the onset of ischaemic versus haemorrhagic stroke in stable coronary artery disease
por: Wang, Wei-Ting, et al.
Publicado: (2021)

Inflammation and renal function decline in chronic coronary syndrome: a prospective multicenter cohort study
por: Kao, Ting-Wei, et al.
Publicado: (2023)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022)

Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease
por: Huang, Chin-Chou, et al.
Publicado: (2020)

Influence of high-density lipoprotein cholesterol on coronary collateral formation in a population with significant coronary artery disease
por: Hsu, Po-Chao, et al.
Publicado: (2013)

Determinants for Achieving the LDL-C Target of Lipid Control for Secondary Prevention of Cardiovascular Events in Taiwan
por: Ho, Li-Ting, et al.
Publicado: (2015)

Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low‐Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients
por: Okerson, Ted, et al.
Publicado: (2017)

Of statins and low-density lipoprotein cholesterol, “fats” and fiction
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2016)

Combination With Low-dose Dextromethorphan Improves the Effect of Amlodipine Monotherapy in Clinical Hypertension: A First-in-human, Concept-proven, Prospective, Dose-escalation, Multicenter Study
por: Yin, Wei-Hsian, et al.
Publicado: (2016)

The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein Cholesterol
por: Al-Sabti, Hilal, et al.
Publicado: (2022)

Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans
por: Doi, Takahito, et al.
Publicado: (2023)

Cost Effectiveness of Inclisiran in Atherosclerotic Cardiovascular Patients with Elevated Low-Density Lipoprotein Cholesterol Despite Statin Use: A Threshold Analysis
por: Desai, Nihar R., et al.
Publicado: (2022)

The Impact of Chronic Kidney Disease on Lipid Management and Goal Attainment in Patients with Atherosclerosis Diseases in Taiwan
por: Lin, Tsung-Hsien, et al.
Publicado: (2014)

The association between statins and subsequent risk of bullous pemphigoid: A population-based cohort study
por: Chang, Tsung-Hsien, et al.
Publicado: (2021)

Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome
por: Tsai, Nai-Wen, et al.
Publicado: (2014)

A Statin-Loaded Reconstituted High-Density Lipoprotein Nanoparticle Inhibits Atherosclerotic Plaque Inflammation
por: Duivenvoorden, Raphaël, et al.
Publicado: (2014)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Familial Resemblance in Low‐Density Lipoprotein Cholesterol Response to Statins in the Danish Population
por: Corn, Giulia, et al.
Publicado: (2022)

Low-density lipoprotein cholesterol, statin therapy, and cerebral microbleeds: The CIRCLE study
por: Zhao, Yuqi, et al.
Publicado: (2023)

Low-density lipoprotein cholesterol lowering therapy for the secondary prevention of atherosclerotic cardiovascular disease
por: Patel, Parth N., et al.
Publicado: (2020)

Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency
por: Chinwong, Dujrudee, et al.
Publicado: (2015)

Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome
por: Im, Jihaeng, et al.
Publicado: (2021)

Jogging and weight training associated with increased high-density lipoprotein cholesterol levels in Taiwanese adults
por: Ho, Chien-Chang, et al.
Publicado: (2022)

Low Levels of Low-Density Lipoprotein Cholesterol and Mortality Outcomes in Non-Statin Users
por: Sung, Ki-Chul, et al.
Publicado: (2019)

Association Between Cumulative Exposure to Increased Low-Density Lipoprotein Cholesterol and the Prevalence of Asymptomatic Intracranial Atherosclerotic Stenosis
por: Kang, Kaijiang, et al.
Publicado: (2020)

Low triglyceride to high-density lipoprotein cholesterol ratio predicts hemorrhagic transformation in large atherosclerotic infarction of acute ischemic stroke
por: Deng, Qi-Wen, et al.
Publicado: (2019)

Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease
por: Shui, Xing, et al.
Publicado: (2023)

Predicting Long-Term Mortality in Patients with Angina across the Spectrum of Dysglycemia: A Machine Learning Approach
por: Li, Yu-Hsuan, et al.
Publicado: (2021)

Triglyceride to high-density lipoprotein cholesterol ratio and total cholesterol to high-density lipoprotein cholesterol ratio and risk of benign prostatic hyperplasia in Chinese male subjects
por: Zhu, Chen, et al.
Publicado: (2022)

Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound
por: Gao, Wen-Qian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pf0uu6697g9355609m7tdf4pq1